comparemela.com

Latest Breaking News On - Corning pharmaceutical technologies - Page 1 : comparemela.com

Corning Incorporated : Q1News Release2024

Corning Incorporated www.corning.com News Release FOR RELEASE - April 30, 2024 Corning Reports.

Taiwan
South-korea
Japan
White-house
District-of-columbia
United-states
Environmental-protection-agency
China
America
Chinese
South-korean
Japanese

Corning Reports First-Quarter 2024 Financial Results

Management reaffirms expectation that first-quarter sales will mark the low point of the year, as improving market conditions support higher sales throughout 2024 Management expects core sales to.

Environmental-protection-agency
District-of-columbia
United-states
China
Japan
South-korea
White-house
Mexico
Taiwan
United-kingdom
British
Mexican

Apple's Glass Supplier Corning Outperforms in Tough Market, Eyes $3B Sales Boost in Three Years - Corning (NYSE:GLW)

Corning Inc reported Q1 2024 core sales decline of 3% YoY to $3.26B, beating consensus of $3.12B. Core EPS of $0.38 also beat consensus of $0.35.

China
United-states
America
Corning-inc
Life-sciences
Optical-communications
First-trust
North-america
Emerging-growth-businesses
Corning-pharmaceutical-technologies
Dividend-aristocrats

Corning Reports Third-Quarter 2023 Financial Results with

Gross margin percentage expanded sequentially on consistent sales and year over year on lower sales; Operating and free cash flow both grew sequentially.

Taiwan
Japan
United-states
China
South-korea
Paris
France-general
France
Japanese
America
South-korean
Chinese

Corning Reports Third-Quarter 2023 Financial Results with Continued Improvement in Profitability and Cash Flow

Gross margin percentage expanded sequentially on consistent sales and year over year on lower sales; Operating and free cash flow both grew sequentially and year over year; Profitability and free cash.

Japan
United-states
Taiwan
South-korea
Paris
France-general
France
China
South-korean
Chinese
Japanese
America

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.